UEQ7:F:F-UBS (Irl) ETF plc - S&P 500 UCITS ETF (hedged to EUR) A-dis (EUR)

ETF | Others |

Last Closing

USD 15.7615

Change

-0.17 (-1.07)%

Market Cap

N/A

Volume

3.87K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-01-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.07 (+0.25%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.15 (+0.30%)

USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.09 (+0.42%)

USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.87 (+0.17%)

USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.15 (+0.29%)

USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

-0.19 (-0.21%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.75 (+0.77%)

USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.06 (+0.42%)

USD 56.18B
VUSA:F Vanguard Funds Public Limited ..

+0.04 (+0.04%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.15 (+0.16%)

USD 49.95B

ETFs Containing UEQ7:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.23% 53% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.23% 53% F 50% F
Trailing 12 Months  
Capital Gain 17.80% 69% C- 65% D
Dividend Return 1.94% 59% D- 20% F
Total Return 19.74% 74% C 56% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.00% 38% F 39% F
Dividend Return 2.20% 40% F 29% F
Total Return 0.20% 58% F 4% F
Risk Return Profile  
Volatility (Standard Deviation) 7.13% 58% F 95% A
Risk Adjusted Return 30.77% 33% F 40% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.